메뉴 바로가기
주메뉴 바로가기
컨텐츠 바로가기

About Us

Company History

2025

  • 04 IMPO88 PLUS, Extracorporeal Shockwave Therapy(ESWT) for urology, Launched
  • 02 Dermashine Duo_RF, a combination device with Radio-Frequency Energy and Drug Injecting Technology, Launched
  • 01 Premium 9-Pin Needle (31G) Launched (For PDLLA Biostimulator)
    HUEN-URO, Endoscope Washer-Disinfector for Urology, Launched

2024

  • 12 Accumulated sales of the 'DermaShine' exceed 20,000 units
  • 07 Established the Customer Service Team
  • 06 Strategic Investment Agreement Signed for Urology Medical Device Business (Medithings)
  • 04 Acquired Chinese patent for the composition of tissue-type disinfectant, Hexiwipes
  • 03 Acquired Import Approval for Chemfort, a Closed System Drug Transfer Device(CSTD)
  • 01 URO-UEMXD, Korea's first lithotripter with an In-Line combination of a shockwave head and ultrasound probe, launched
    MT-3000, Extracorporeal Shockwave Therapy(ESWT) device Launched
    Acquired Import Approval for Tulsa-Pro, a robotically-assisted, Incision-free solution for prostate disease

2023

  • 12 Awarded the $7 million Export Tower and Presidential Citation
  • 11 Obtained ISO 37301 Compliance Management System certification
    Acquired Import Approval for Sonalleve, a HIFU device for uterine fibroids
  • 09 Acquired the ESWL business division of M.I.Tech Acquired TFDA(Taiwan) Certification for Dermashine Pro
  • 06 Hosted the URO-MXD Launching Symposium
  • 05 Premium 9-pin Needle Launched
  • 04 Huons Meditech, Selected as a Great Place to Work

2022

  • 02 Establishment of Huons Meditech (Merger of Huons Medical - Huons Medicare)

2021

  • 12 Acquisition of integrated certification for safety and health management system.

2020

  • 04 Selected as an export voucher business (KOSMES)
  • 03 "Scotelin Plus" product registration completed (China)

2019

  • 12 Selected as Leading Company of Strategic Industry in Busan City (Life Care Sections)
    Investement contract for joint development of healthcare robot business (Zeta Bank)
  • 07 ISO 9001 Certification (Seongnam Branch)
    Selected as a Busan hidden champion company (Busan City)
    Designated as a promising export small and medium business Administration
    (Ministry of SMEs and Startups)
  • 05 Designated as a research and development venture company
  • 04 Disinfectant Tissue for human skin "Hexiwipes" approval
    ISO 13485 certification (Seongnam Branch)
  • 03 Ophiclean® CE Mark approval
  • 01 Acquired "Medical Device Business Sector" from "WeGreen Inc."

2018

  • 09 Established additional production lines (Disinfectant Tissue)
  • 08 Launching single use collyrium Lybliss 0.15% & Lybliss 0.3%
  • 04 Single use Peracetic Acid (PAA) Disinfectant "Sco-Single" approval
  • 03 Automatic Endoscope Reprocessor (AER) WELL-1 & WELL-2 approval
  • 02 Peracetic Acid (PAA) Disinfectant "Scotelin® Plus" approval

2017

  • 10 Medical device manufacturing industry approval
  • 08 Acquired "Medical Device Business Sector" from "M Technology Inc."
  • 04 Changed name to Huons medicare Co., Ltd.

2016

  • 05 Huons Group changed into a holding company system
  • 01 First disinfectant exportation to Japan (Company "KRD JAPAN")

2015

  • 09 Signed export contract to China on Scotelin® (Company "Carewin")
  • 06 Changed Representative Director & CEO (Mr. Lee Sang Man)

2014

  • 03 Changed Representative Director & CEO (Mr. Jeon Gyu Seop)

2013

  • 10 Patent application for Peracetic Acid (PAA) dialysis solution composition without acetic acid ion.
  • 08 Emofen-C Tab. L-car Inj. approval
  • 06 Ridifen eye drops, Ritobra eye drops, Rioflox eye drops, Riflu eye drops, Riflu-T eye drops, Ritobra eye drops approval
  • 04 Changed name to Huniz Co., Ltd.
  • 01 Rebliss eye drops (Sodium hyaluronate), Hexi-al solution 2% (Chlorhexidine gluconate) approval

2012

  • 12 Ritanol eye drops (Olopatadine hedrochloride) approval
  • 09 Huniz Fluconazole Cap approval

2011

  • 06 Acquiring item (Elprin Tab)

2010

  • 07 Changed Representative Director & CEO (Mr. Lee Sang Deuk)

2009

  • 12 Awarded with excellent firm for KFDA self-audit
  • 07 Acquisition of quality certification for sanitary product and GH mark (Hemoclean®, Scotelin®)

2008

  • 10 Patent application of manufacturing method for Peracetic Acid solution with new technology
  • 07 Hold the first "Int's Hemoclean Conference"

2007

  • 12 Awarded $ one million export
  • 11 Written in casebook about success of support of the policy
  • 01 Designated as leading company of top 10 business strategy

2006

  • 06 KFDA for Korea's first PAA - "Hemoclean®, Hemoclean® RP" approval

2005

  • 09 Designated as an excellent small-medium enterprise and enterpriser
  • 08 Awarded with 2005 Venture enterpriser

2004

  • 10 Affliated laboratory received citation for "Man of Merit in Science and Technology Promotion" (The Minister of Science and Technology)
  • 04 "Hemoclean®" received world's first FDA approval on "PAA based disinfectant for artificial kidney"

2003

  • 11 Selected "Top 100 Excellent Patents in Technology 2003" (Korean Intellectual Property Office (KIPO), The Hankook Ilbo (韓國日報))
  • 02 Awarded "Korea's Exellent Venture Company" (Seoul Economy Newspaper)
  • 01 Changed Representative Director & CEO (Mr. Lee Jin Tae)

2002

  • 12 Won the grand prize in "Digital Innovation Awards 2002" (Minister of Commerce, Industry and Energy Award)
  • 08 ISO 9001, 13485, SGS UK, "Hemoclean®" CE Mark
  • 04 Completion of Clean Room (KGMP, CE, cGMP standards)
  • 01 Signed 3 million USD export contract on "Hemoclean®" (Gambro K.K., Japan)

2001

  • 05 Received official approval on "Affiliated Medical Chemistry Laboratory" (Korea Industrial Technology Association (KOITA))

2000

  • 04 Patent application for Peracetic Acid (PAA) production method
  • 01 Started marketing "HEMOCLEAN®"

1999

  • 10 Establishment
  • 03 First developed Peracetic Acid (PAA) for medical device cleaner & disinfectant in Korea